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THE INDUCTION OF TITY- 1 . 2 ANTIGEN EXPRESSION I N MURINE 
BONE I1ARROw CELLS I NCUBATED IN VIT RO \'lITH 
ml'iUN E SERUI·j 
Terry J . Knight I-j ay 1978 45 pac;es 
Directed by : Dr . Fernando ~l orgado, Dr . James Skean, 
and Dr . Scott Ford 
Department of Bio l ogy \-Iestern Kentucky University 
Adult BALB/c mice were immunized with C57BL/ 6 spleen 
cells f i rst on day 0 and a gain on day 8 of the experi mental 
procedure . Serum ViaS collected from these animal s on day 
o ( be f ore the f irst i mmunization), day 4 , day 8 ( before t he 
s econd i mmuniza t ion) , day 12 , and day 16 . Two , roups of 
normal BALB/c bon e marrow cell suspensions were i nc ubated 
with the experimental i mmune sera; and one of the gr oups 
of cell suspensions was subsequen t l y incubated with bacterial 
lipopolysaccharide . Following the i ncubat ion steps, both 
groups of cell prepa rations were assayed for their abilit y 
to absorb the activity of the anti- Thy-1 . 2 serum. 
Subsequent testing of the res idual anti- thymocyte 
cytotoxic activity of the absorbed anti- Thy- 1 . 2 sera re-
vea led that t he bone narrow cells incubated with day 4 and 
day 8 i mmune ser a exhibit an increased capacit y to a bsorb 
the antiserum compared to control bone marrows . These 
observations offer positive evidence for the existence of 
a feedback mechanism in animals under oing forei gn tissue 
graft rejection; the proposed mechanism apparently provides 
a circulating , non cellular substance which is capable 
of induc ing bone marrOl'i T- cell differentiation . 
'l'be central problems in immunobiology today 
revolve around the ellucidation of the pathways and 
mechanisms through which l ymphocytes with immune re-
active capabilit ies a re de veloped f rom undifferentiated, 
unresponsive progenitors . In order to simpli fy the 
postulation and manipulati on of hypotheses aimed at 
addressin~ the problems , the vertebrate i mmune sys t em 
has been provisionally d ivided into two broad categories 
of responses . 
The B- axis, bursa- equivalent system, or t he humoral 
i mmur.e response , f irst discovered to be housed in the 
avian bursa of Fabricius ( 1 ) , provides effector cells 
which synthesize and release freely diffusible i mmuno-
globulins Vlh ic h bind to and inactivate f oreign or aber-
r ant macromolecules . The actual equivalent of the bursa 
has not been determined f or non-avian vertebrates, but it 
is lmOlm , however , t hat t he bone mar r oV! t issues command 
the capacit y of producing cells whi c h are prec ursors to 
the functional, mature B cells (2), and that , in birds , 
these marroVl , B- precursor cells prohably undergo func t ional 
maturation under the influence of t he hursa (3) . 
Cellular immunity is th e second broad category 
of t he i mmune s ystem. This type of immunity has also 
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been called the T- axi s or thymus- dependent lymphocyte 
immune response; and the cells involved in the reactions 
are re£erred to as thymocytes and/or T cells (4) . Among 
the major t ypes o£ immune responses which are T-cell 
mediated are delayed hypersensitivi ty (5), allogra£t 
rejection and its counterpart , the gra£t- versus- host 
response ( 6 ), and the in vitro mixed l ymphocy te reaction 
(7) . In addition to the T- cell r eact ions listed above, 
T cells have been reported af: participating s ynergjstically 
with B cells in r esponses to some types o£ antigens ( 8) 
as '.'Iell as exerting an immunosuppressive in£luence on the 
host ' s i ffiQ une response to antigens under certain conditions 
( 9) . In brier summary , T cells are divided into t hree 
groups: i ) e££ector cells , ii) helper cells , and iii) sup-
pressor cells . 
Although r ela tively little is known about £actors 
in£luencing the d evelopment o£ t he B- axis r esponse (3) , 
T- cell development and di££erentiation have been t he 
£oci of intense investi~ative e£for ts in laborat ories 
durin g the past decade. The re l atively greater proli£-
eration o£ re search into T- cell devel opment can be as-
cribed to the greater £easi bility of rec ognizing T cells 
and their pre~ursors compared to that o£ the B cells and 
B- precursors \~hich continue to resist detection (10) , 
The existing technology which permits T-axis 
experimentation is based on the £act that T cells and 
their precursors ( pre-T cells) exhibit several antigenic 
determinants on their membranes which are, £or the most 
part, detectable by relatively simple laboratory 
methods , e. g., cytotoxicity s tudies (11, 12); and 
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their presence or absence on a cell is interpreted as 
indication of t he cell ' s level of development and/or 
functional potential (10, 13). So~e of the markers 
specific for murine T cells (i . e . , antigenic determi-
nants present only on T cells and absent on B cells) are 
GIX (14); Thy- 1 (1 5) ; BA9, or brain-associated theta (1 6) ; 
TL , of thymus leukemia (17) ; NSLA ,or mouse s pecific 
lymphocyte anti gen (1 8); and LY (1 9) . Among the deter-
minants listed, the Thy- 1, or e antigen, has been of great-
ast value in T-cell investigations,with the TL marker 
trailing as close second. 
The Thy- 1 antigen is a structure which in nature 
is expressed on T-axis cells as well as on cells in 
tissues of the brain (15, 16 ). Since the determinant is 
a gene product in mice, it exists in two allelic f orms, 
which are Thy- 1.1 and Thy-1 . 2 , corresponding to 9Al':R 
and 9C3H, respective l y, of earlier literature . The 
fact that Thy-1 is so extensively expressed on thJ~ ocytes 
great l y fac i litates the preparation of antisera specific 
for either of the allelic f orms by immunizing mice of 
one Thy-1 genotype ~Iith thymus (or brain ) s uspensions 
from mice having the opposite constitution (20). The 
purified antisera can subsequently be utilized in cy to-
toxicity testing to detect the presence of the antigen 
for which the reagent is specific (11, 12) . 
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Through conaideration of experimental evidence 
accumulated to date, the i mmunological differentiation 
and development of T cells can be interpreted as por-
traying antigenically naked embryonic progenitors 
(referred to as null cells) which migrate from the yolk 
sac to the fetal liver. As the organism c ontinues to 
develop , there is a further sequential migration to the 
bone marrow and finally to the thymus gland where, under 
the influence of a \"Jell characterized hormone- like sub-
stance , t hymopoietin (11, 21, 2) , these cells express 
T- cell anti gens which are s pecific for a given l evel of 
cell maturity (1 9) . Upon leaving the thymus and entering 
the circulatory system and/or l ymphatic tissues, the 
cells undergo final maturation and aqui re t he functi0nal 
attributes of T cells of the a bove characterized t ypes . 
'liith the development of sens i tive moni t oring 
assays (11 , 12 ) it has become clear that t here are T-cell 
precursors (committed to the T program) in adul t bone 
marro\'/ in which the expression of the Thy-1 antigen 
can be induced by in vitro incubation with thymopoietin . 
The effect of thymopoietin i n this circum stance is t o 
t rigger t he expression of an antigen on a cell in .'hich 
the genetic potential already exists (2) . Th is eff ect 
is especially dramatic in the case of the congenitally 
athymic mouse in which the absence of thymic influence 
results in the absence of T-cell function . However , 
these mic e do possess the genetic wherewithal for T-
cell activity , and, upon treatment or the animals with 
thymic factor or thymus implant s , the cellular i mmune 
runctions are restored (23) . 
Most research to date has indicated that T- cells 
either do not normally exist in bone marrow or that 
thei.~ presence in that compartmer, t is negligible . 
There have been reports or slight bone marrow T cell 
activity by some workers (24) , and this activity seems 
to VRry among dirferent genetically derined strains 
(13, 25) . The purpose or the ~resent research was to 
investi ga t e f urther the presence of T cells in bone 
marrows of genetically dirrerent strains or mice and 
to determine ir, arter injection or an antigen , a ractor 
could be recovered in the serum which could induce 
the expression of Thy-1 antigen in normal mouse bone 
marrow upon in vitro incubation. Such a model would 
serve as an indicator or a r eedback control system in 
the in vivo situation . A positive resul t wou ld. pro-
vide evi dence to support the heretorore unsubstantiated 
notion or antigen- induced stimulation or bone marrow 
lymphopoiesis through a humoral r actor produced in 
response to an antigenic challenge . 
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l'iATERIALS AND METHODS 
Animals 
I nbred strains of BALB/c (H_2d , Thy-1. 2), C57B~/6 
(H_2b , Thy-1. 2), and C3H/Cum (H_2k , Thy-1.2) mice were 
purc hased from Cumberland View Farms , Cl inton, Tennessee; 
inbred AK H/J ( H_2k , Thy- 1 .1 ) mice were pu rchased from 
Jackson Laboratories, Bar Harbor, Maine . All mouse 
strains were maintained and bred in the animal room 
of the Department of Biology at Iyes tern Kentuc ky Univer-
sity and were given food (Lab Chow, Ralston Purina Co ., 
St . Louis, Ho.) and fresh tap wat er ad libi tum . Adult 
and experimental animals were segregated according t o 
sex and were housed i n groups of 6 to 8 in plastic c a ges . 
Anti ~rhy-1 . 2 Serum 
AI\H/J s erum anti-C3H/HeJ v/as purchased from Litton 
Bionetics, Inc . (5516 Nicholson Lane , Kens ington, 11d . ) . 
The antiserum was stored at -40· C in a Hevco f reezer pend-
ing use, and all precautions were taken to prevent un-
necessary thawing and freezin g of the reagent. 
Cytotoxicity Testing 
For the purpose of evaluating the activity of the 
anti Thy-1.2 sera against BALB/c thymocyte suspensions, 
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the f ollowing protocol was observed. The techni que 
used represents a modification of a procedure recom-
mended by the manufacturer of the antiserum (Technical 
Sheets, Litton Bionet ics) . Unless othe rwise specified, 
all procedures were performed with sterile reag:nts 
and sterilized equipment . 
Preparation of ThymoCyte Suspensions 
The thymus gland from one 4- t o 6- week- old BALB/c 
mouse was surgically removed foll owin g the kil l ing of 
the animal by cervical disarticulation . The gl a nd 
was placed into a Glass petri dish containing cold 
(4 · C) HPM I -1 640 tissue culture med iu m with glutamine 
(Grand Island Biological Company , Grand I sland , New 
York : GIBCO) penicillin 100 units/ml , and st reptomycin 
100 )lg/ml (GIBCO) added (this preparation wi ll hereafter 
be referred to as HP1H) . Ca re was taken to avoid con-
taminating the tissue wi t h blood , and all vis ible vas-
c ul ature was carefully removed . Following this init ial 
treatment , the remaining tissue was transferred t o an-
other (sterile) petri dish containing a fresh volume 
of RPN I . After carefully teasing apart the tissue mass , 
the smaller fra gments were di s rupt ed into a cel lular 
suspension by gentle syringing through 18- , 20-, and 
22- gauge hypodermic needles attached to a 3-ml dispos-
able plastic syringe . Following this maneuver, the 
preparation was transferred to a 15-ml conical glass 
centrifuge tube, and the volume of the sUspension 
\'las adjusted to appr oximately 5 ml \'lith RPNI. 
The suspended cells were then centrifuged at 
250 x g for 15 min at 4 ·C in an lEe PR- J refrigerated 
centrif uge (Damon/lEe Division, Needham Heights , r.lass . ); 
the supernatant was discarded; and the cell pellet was 
resuspended in 5 ml of cold (4 ·C) phosphate buffered 
saline (PBS) (Dulbecco's PBS without Ca and Mg , pH 7 . 3) 
by pipetting the cell pellet in a 9 - in pasteur pipet. 
The suspension \~as then recentrifuged per above, and, 
after discarding the supernatant , the cells \~ere again 
Suspended in 5 ml of PBS and centrifuged . The three sus-
pension and centrifugation steps constituted a washing 
sequence performed for the purpose of removing autolo-
gous serum constituents . 
After the final centrifugation , the Supernatant 
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was discarded and t he remaining cell pellet was resuspend_ 
ed in 1. 5 ml of RP~:I , prepa red as above except with t he 
addition of fetal cal f serum (GIBC O) , to a final con-
centration of 10% (this augmented medium wjll hereafter 
be referred to as RPHI - FCS) . The concentrat ion of the 
cells in the suspension was determined by dilu ting one 
vOlume of the suspension in 10 volumes of diluting fluid 
(0 . 2% acetic acid and crystal violet) and counting by hemo-
cytometry . Five square areas in two counting chambers 
were counted in order to obtain a realistic assessment 
of the actual number of thymocytes present in 1.0 ml of 
suspension. Once the concentration was determined. the 
suspension was f urther diluted with co ld RPM I-FCS to a 
final concentration of 2 x 106 thymocytes/ml of suspen-
sion, and the preparation was covered and stored on ice 
pending use in the assay procedure described below. 
r'J odif ied Assay of Ant iserum-
Mediated Cy totoxicity 
Cytotoxi city incubations and assays were carried 
out in clean rhcrotiter test plates ( Nicrotiter, Cooke 
Laboratory Products , Al exandria , Virgi n ia ) as follows : 
Doub~ jilutions of the ant i Thy-1. 2 serum were made 
using RPrlJ I as the dilutent . Duplicate 0 . 025 ml volumes 
of the 1 : 20 , 1:40 , 1: 80 , 1:160 , and 1: 320 di l uted anti-
serum were dispensed in t o separate wells of one t est 
plate us ing pipets calibrated to deliver that volume 
( Pipette Droppers, 0 . 025- ml de livery , d i sposable, Cooke 
Laboratory Products , Alexandria , Virginia) . RPV. I and 
c omplement (see be low) control wells were established 
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by dispensing 0 . 025 ml of RPtU into each of 6 separate wells . 
Following the addition of 0 . 025 ml of the ce l l 
suspension ( 2 x 106 c e l ls/ml) to each of the antisera 
and control wells, the plates were covered and gently 
a gitat ed t o ensure nixing of the contents , and then 
t hey were incubated for 1hr at 4·C in t he laboratory 
refrigerator. After the 4·C- incubation step, 0 . 025 ml 
of gu inea pig complement (GPC, non-sterile, GIECO) di-
luted 1: 6 . 6 in RPM I was added to each antiserum test 
well and also to half of the control wells; 0.025 ml 
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of RPfolI-FCS was added to the r emaining control wells and 
the plates we re a gain covered and a gitated gently . 
The prepared test plates were subsequently enclosed 
in a humidified incubation chamber (Modular Incubator 
Chamber, Billups-Rothenberg , Del l'1ar, CalifoI11ia) into 
which an atmosphere of 10% CO2 + 90% air was introduced; 
the chamber was then placed in a 37 · C- incubator for 1 hr. 
Following t he 37 · C- incubation step , the plates were 
removed from the chamber and placed in direct contact 
with crushed ice for 5 min; 0 . 050 ml of 0.2% trypan blue 
dye solution (GIBCO , d iluted in PBS) was added to the 
individual well s , and the content of each well were 
thouroughl y mixed by pipetting up and down ten times 
through a clean pasteur pipet . It should be noted that 
the dye was not added until immediately before count ing 
the cells, and the remaining wells in the plate were 
kept covered on ice in the interim between the start and 
the finis h of the procedure. After the well contents 
had been mixed, the suspensions were used to fill hemo-
cytometer chambers , and the cells were scored as alive 
or dead by light microsc opy inspection. In order to 
qualify as a living cell , the cell under consideration 
had to appear white with a sharply defined border as 
compared to a dead cell which appeared either swollen 
and blue or light blue with an ill-defined cytoplasmic 
border. Red cell contamination was minimized by ob-
serving the precautions described earlier in this paper. 
The cytotoxicity of each serum was determined by 
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counting 200 cells and determir.ing the percentage of 
c ell mortality in each chamber. A Cytotoxic Index (C .I.) 
was then calculated as : 
C.l.= % mortality experimental - % mortality control 
100 - % mortality control 
The percentage of mortality in the control wells 
was de termined before and after each replicate of the 
a ssay for the s erum series , and the value of % mortality 
control f or the C. I . calculations was set equal t o the 
highest % mortality obtai ned i n any control i mmediately 
before or after the experimental sera were assayed. The 
final C. I . value was recorded as the average C. I. of 
the replicate assays. 
Preparation of Thymus and Bone r1arrow 
Cell Suspensions f or Absorption of 
Anti-Thy-1.2 Sera 
Bone marrow c el ls from several i nbred s trains and BALB/c 
thymocytes were prepared for subsequent testing of thei r 
ability to absorb an t i-Thy-1 . 2 serum at various dilutions . 
Although the antiserum dilution and the number of absorb-
ing cells used \-Ias varied in different experimen ts (see 
l ater) , the preparation of the cell suspensions and the 
test plates followed the same basic design . 
The thymus glands from 4- to 6 -\" eek old BALE/c mice 
were surgically removed, and cell suspensions were pre-
pared according to the procedure described previously 
(see Cytotoxicity Testing) with one modification: 
after the final centrifugation step in the protocol, the 
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cells vlere resuspended in RPMI f or the purpose of count-
ing (instead of RPNl - FCS) and the final cell concentra-
tions were adjusted with RPrH suc h that 0 .1 0 ml of the 
cell suspension would contain the number of cells desired 
for the absorption. 
Bot h femurs of t he bone marrow donors were s ur gi-
cally removed and pl aced into a petri dish containing 
cold HPMI . Eac h bone was carefully cleaned of musculature 
and t hen p laced into a clean petri dish containing RPIU . 
After all bones had passed the initial cleaning , the ends 
of eac h bone vlere cut of f and t he contents of the marrow 
cavity were expel led int o a cooled 15- ml conical glass 
centrifuge tube by flush i ng t he bone with cold ( 4 ' C) 
RPl'iI- FCS (using a 3- ml disposable plastic syringe f itted 
with a 22- gauge needle) . Aseptic precautions were 
observed throughout the procedure and all work I_as per -
formed over a bed of crushed ice . 
The cells vlere sus pended in 5 ml of RPllI , and the 
c ell clumps were disrupted by gentle s yringing of the 
suspension t h rougb 18-, 20-, and 22- gauge needle s . Large, 
undisrupted fragments were allowed to se ttle to t be 
bottom of the tube , and after the supernatant vIas visibl y 
clear of undisrupted fragm ents (afte r about 2 min ) , 
it was transferred to a clean 15-ml conical cent rifuge 
tube. 
The suspended cells ~Iere then centrifuged at 
250 x g for 15 min at 4'C in an lEG PR-J refrigerated 
centrifuge. The supernatant was discarded an~ the cell 
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pellet was resuspended in 5 ml of RP~lI, and the resul t -
ing cell suspension was a gain centrifuged f or 15 min 
per the above specifications . 
After the second centrifugation , the supernatant 
was discarded and the cell pellet was resuspended in 
1.0 ml of RP~j I by gent l e syringing throu gh a 22- gauge 
needle . 
The concentration of cells was determined by count-
ing in a hemocytometer (see previous) and the final con-
centration was adjusted in HPN I so that 0 . 10 ml of the 
cell suspension would contain the number of cells desired 
for the particular a bsorption . 
Absorption of Anti- Thy- 1 . 2 Sera with 
Bone ~larrow Cells or 'l'hymocytes 
Treated (see belo~l) or untreated bone marrow 
or t hymus cell suspensions were incubated with various 
d;.lutions of anti-Thy- 1 . 2 serum in order to t est the 
cells for their ability to absorb the antiserum act ivity . 
Anti -Thy-1 . 2 serum was diluted 1:10 , 1: 20 , and 1 :40 in 
HPfH , and 0 . 10 ml a liquots of the desired s erum dilution 
were placed into duplicate 10- x 75-mm culture tubes to 
which 0 .10 ml aliquots of the appropriate cell suspensions 
were added . Duplicate control tubes containing 0 . 10 ml 
of the diluted antisera and 0 .10 ml of RPMI were prepared 
as sham absorptions. All tubes were first a gitated gent-
ly to ensure thorough mixing and then incubated for 
1.5 hr at 37 ·C in a humidified 10% CO2 + 90% air environment 
Folloldng incubation , the tubes were placed int o 
an lEG model CL centrifuge and centrifuged f or 15 min 
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at the maximum velocity obtainable with that device . This 
technique proved to pellet the cellular frac tion of the 
suspension effectively and permit the supernatants 
to be collected . The supernatants were carefully drawn 
off in sterile pasteur pipets and transferred to 6- x 50- mm 
culture tubes in which they were stored at -40 · C pending 
analysis of their residual cytotxic activities. In 
the absorption of the antiserum with bone marrow cello 
treated with either i mmune sera and/or bacterial lipo-
polysaccharide (see belo~/) the volumes of the antisera 
and the cell suspensions were doubled to faci litate ma li -
pulation ; in other 1"OrdS, O. 20- ml aliquots of the anti-
serum I'/ere mixed VIi th O. 20- ml aliquot s of the bone marrow 
cells . 
Preparation and Collection of 
BALB/c Anti-C 57BL Immune Sera 
BALB/c adult mice I~ere i mmunized VIi th tVIO i njections 
of C57BL/6 spleen cell suspensions , and sera were 
collected periodically over a 16- day period . The serum 
was collected from 17 BALB/c adult (14 weeks old) male 
and female mice 6 hr prior to injecting them with C57BL/6 
spleen cell suspension on day O. Serum collections were 
subsequently made on days 4, 8 , 12, and 16 , and the sera 
were prepared in the manner described below. 
The donor mice were placed ( one at a time) in a 
styrofoam container equipped with a 100- watt heat lamp 
located at the top. The lamp was turned on and the 
mice were heated for approximately 45 sec to effect 
vasod ilation . Upon removal , the mice were bled from 
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the t ail by making a deep cut on the ven t ral side of the 
tail ; approxi ma t ely 15 drops of blood were collected 
f rom each animal . 'r he bloods from all animal s we re 
pooled , and the pooled blood spec i men was incubated 
for 1 hr at 3TC t o allow clot formaUon . In an a ttemp t 
to a void excessive hemolysis , t he clot was carefully re-
moved from the specimen prior to centrifuging it for 15 
min in an lEG model CL centrifuGe at the maximum setting . 
Fi nally , the clear , cell- free supernatant was caref ully 
removed and stored at - 40 ' C pending furt her use . 
The spleens of 6 C57BL!6 mal e and f emale mice 
(1 2 to 16 I-/eek s old) were surgically removed and placed 
into a petri d ish contain i ng cold (4 ' C) iU'f'lI . 'l.'he or gan s 
were ~ently t eased apart with forceps and the resul t ing 
small f ragments were fu r t her disrupted by gen tly sy ring-
in~ th e mixture through 18-, 20-, and 22- gauge needles 
as described previously f or other cel l suspensions . 
The cells were then mixed with a large vo lume of RPM I , 
t r ansferred t o a 15- 101 conical glass centrifuge tube, 
and centrifuged at 250 x g fo r 15 min at 4'C in an l EG 
PR- J centrifuge. After centrifugation , the supernatant 
was discarded and the cell pellet was resuspended in 
2 101 of RPMI . The cells were counted in a hemocytometer 
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(see previous ) and the fina l concentration ~/as ad justed 
with RPi'1I . 
Ultimately , t he serum donor mice each received an 
i ntraper itoneal (i . p . ) injection of 20 x 106 C57BL spleen 
cells in a total volume of 0 . 06 ml . Serum ~Ias collec t ed 
a gain on days 4 and 8 of the experiment and stored at 
- 40 · C. Six hours after the collection of serum on day 
8 , the serum donor animals received a second i . p . injection 
of 55 x 106 C57BL spleen cells in a total volume of 0 . 65 ml . 
The spleen donors f or the second in j ection were C57BL 
male and female mice (1 6 to 20 weeks old) and the 
spleen cell suspension was prepared hy the same method 
described above . Serum ( BALB/c) was a gain collected on 
days 12 and 16 of the expe r i ment and stored at - 40 ' C 
pending use in the in vitro incubat ion with bone marrovl 
desc r i bed be l ow . 
Incubation of BALB/c r·la rrow Suspensions 
with Sera and/or LPS 
NOTE : This procedure l'/as the f irst step t oward 
t he pr eparation of ant i - Thy- 1 . 2 serum absorbed a gainst 
treat ed bone marro~/s . 
BALB/c bone marrow suspensions were prepared 
according to the technique described previously at a 
concent ration of 2 x 107 cells/ml in RPru . An excess 
volume of the suspension l'/as prepared in order t o a l low 
a margin for insidious loss of volume due t o the l ogis-
tics of the procedure . 
I nc ubation 01 the t1arrO\. Suspensions 
with the Experimental Sera 
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Duplicate 0 . 20- ml aliquots of the cell suspension 
were placed into 12 sterile 10- x 75- mm culture tubes 
(i . e ., 4 x '106 cells total in each tube) . Duplicate 0 . 20- ml 
aliquots of t he control ( RPtlI ) and each experimental serum 
(co ' lected on days 0 , 4 , 8 , 12, 16) were placed into t he 
culture tubes cont aining the previously prepared cell 
s us pensions . ,; 11 tubes were p;ently agitated to ensure 
t hourough mixing of t he contents; and t he t ubes were i n-
c ubated f or 2 hr a t 37 ' C in a humidified environment con-
taining 10% CO2 + 90% air as described previously . 
Following the first inc uba t ion , all culture tubes 
vlere centrifuged at room temperature in an I =C centrif uge 
model CL for 15 min at the maximum velocity obtainable 
wi t h tha t device . The resulting supernatants were disca rd-
ed and t he pell eted c ells wer e t hen inc uba ted with e i t her 
bacterial LPS (see below) or anti- Thy- 1 . 2 s erum i n accord-
ance with t he protocol described belO\ • • 
Inc ubat i on 0 1 t j e Serum Treated Bone ~j arrow 
Cells with Bacterial Lipopol~' saccharide 
One of t he two groups of treated bone ma r row cell 
preparations received 0 . 20- ml aliquots of bacteri al 
lipopolysaccharide (Bacto Lipopol ysaccharide \~ , E. coli 
0111:B4 , Difco Laboratories, Detroit , Nichigan; here-
after referred to as LPS) diluted to a concentration 
of 5 pg/0.1 ml in PBS . All tubes were a gitated to re-
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suspend the cell pel lets . 
The LPS- treated cells were then incubated f or 2 hr 
at 37 · C in humidified 10% CO2 + 90% air . Following 
incubation I~i th the LPS , the c ulture tubes were cen -
trifuged at room temperature in an lEC centrifuge 
(model CL) for 15 min a t the maximum setting , and t he 
supernatants (containing LPS) .Iere discarded . The re-
maining ce l l pellets were incubated vii th anti- Thy- 1 . 2 
serum in accordance I~i t h t he protocol described below . 
Equal 0 . 20- ml aliquots of the anti- Thy-1 . 2 serum 
diluted 1 :10 or 1 : 20 vlere dispensed into culture t ubes 
containing groups of cells previ ously incubated wi t h 
either experimental sera followed by LPS or incubated 
only l'lith experimental sera . All tubes were a gi t ated 
to resuspend the ce l l s in t he antiserum and t hen incubated 
for 2 hr at 37 · C in humidified 10% CO2 + 90% air . After 
t hi s fina l incubation step , t he cell p repa rat i ons were 
a gain centrifuged for 15 mi n in the l EC model CL 
centrifuge at t he maximum s ettin c; , and t he supernatant s 
were care f ully r emoved and stored at - 40 · C pendin 
assessment of t heir residual cJ t otoxic activities . 
The residual anti- thymocyte cy to t oxicities were 
calculated for the bone- marrovl- a bsorbed antisera . To 
de termine the percentage of absorpt ion (% Abs . ) of the 
anti- Thy- 1 . 2 activity , the cytotoxic indices (C.l . ) of 
the experimental, marrow- absorbed antisera (C . l . exp . ) 
was compared to the C.I. of the sham- absorbed antisera 
(C . I . sham) in the following equa t ion : 
% Abs . = C. I . sham - C. I . exp o x 100% 
C. I . sham 
Summary of the Experimental ~l odel 
In an experiment designed to de t e rm ine whether 
or not BALB/c bone marrow cells coul d be induced to 
express the Thy-1. 2 antigen by in vitro inCUbation 
with isologous immune sera , normal BALB/c bone marrow 
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cells were inc ubated for"- hr ~Ii th the experimental sera 
whic h were collected on days 0 , 4 , 8 , 12 , and 16 as 
described previously . The presence or absence or the 
Thy- 1 . 2 antigen ~Ias determined by a bso rbing anti-'I'hy-1. 2 
serum diluted 1 : 10 and 1 : 20 in RPrH with the treated bone 
marrow cells; fol lowing the absorption step , the anti -
sera (supernatants) were tested f or residual cytotoxic 
activity against BALB/c thymocytes . ( Fi g . 1) . I n a 
compan ion experiment designed to dete rmine t he relat i ve 
extent of Thy-1. 2 expression in experimental sera-treated 
bone marrow cells f ollowing treatment with LPS , a mod-
i f ication of the above, basic model was used . After 
the 2 hI' incubation with the experimental sera, the cells 
were incubated f or two additional hours with LPS , and 
then they were used to absorb the anti Thy-1. 2 serum 
diluted 1:10 and 1: 20 in RPMI. 
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Figure 1. Model of t he experimental procedure; mice were 
also immunized on day 8 (see text) . 
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RESULTS 
Direct Cytotoxicity of Anti-Thy-1.2 Sera 
Against BALB/c Thymocytes 
In o1uer to assess the cytotoxic activity of the un-
absorbed anti-Thy-1.2 serum a gainst BALB/c thymocytes, 
serial <iou'oling dilutions of the antiserum were assayed 
a gainst a constant number of the target cells. Early 
tests of the cytotoxicity of anti-Thy-1. 2 sera a gainst 
C3H and BALB/c thymocytes indicated that the C3H cells 
were more refractory than BALB/c cells in their response 
to the antiserum; thus, in the interest of minimizing the 
amount of antiserum needed for any given determination, 
BALB/c thymocytes were chosen as target cells. 
Figure 2 represents the results of a t ypical ex-
periment. In this and other tests it was found that the 
anti s erum diluted 1:20 had a very hi gh titer of activity 
a gainst the target cells as testified by cytotoxic indices 
of 0.90 and greater. Cytotoxicity of the antiserum 
(measured as C. I . ) was found to drop in a characteristi-
cally linear manner upon increasing dilution. It should 
be noted that the horizontal axis in Figure 2 represents 
logarithmically increasing dilutions. 
The C.I. reported here represent determinations 
which were made using an antiserum volume to cell number 
ratio of 0.025 ml of diluted antiserum: 0.025 ml x ( 2 x 106 
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Fi gure 2 . Direct cytotoxicity of anti- Thy- 1 . 2 serum 
dilut ions a gainst BALB/c thymocytes; each 
point represents the average of two values 
obta ined in a typical experiment . The 
dashed line indicates the gapped jump f rom 
one dilution to the next , whereas the 
solid line represents the general profile 
of the response to increasing dilut ion. 
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cells/mI. If this ratio were not adhered to it would be 
expected that the profile of the response curve would be 
altered. From this preliminary determination of anti-
s erum titer it was concluded that the antiserum would 
have to be used at a maximum dilution of 1:20 in the ab-
sorption experiments in order to preserve the hi gh end 
C. l . (0.90 or gr eater) in subsequent testing of the anti-
sera for residual activity . 
Ability of BALB/c Thymocytes to Absorb 
Anti- Thy-1 . 2 Activity 
Anti - Thy-1. 2 serum diluted 1:40 was tested for its 
residual cytotoxic activity followin g incubation with a 
graded number of BALB/c thymocy tes . This experiment was 
performed for the purpose of determining whether or not 
cells bearing the Thy- 1.2 antigen ( viz . , BALB/c tbymocytes) 
were able to absorb or otherwise remove the activity of 
the antiserum. The 1:40 antiserum dilution was chosen 
in preference to t he 1: 20 dilution because it had previous-
l y been shown ~ee above) that the 1:20 dilution exhibited 
a high titer of activity . As such, the 1 : 20 dilution 
would be expected to be relatively insensitive to ab-
sorption by the cell concentration used in this experi-
ment e 
The results presented in Fi gure 3 portray a si gmoid-
shaped curve, indicating that the antiserum was relative-
ly insensitive to absorption by 104 - 105 cells. There 
was, however, an apparently linear decrease in the 
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Figure 3 . Anti BALB/c thymocyte activity of anti-
Thy- 1 . 2 serum previously absorbed with 
increasing numbers of BALB/c thymocytes ; 
each point represents the average of 
two determinations; £ = unabsorbed control . 
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activity of the antisera which was absorbed with 2 x 105 -
106 cells, and it was found that 2 x 106 cells complete-
ly absorbed the anti-thymocyte activity of the serum. 
From these observations it was concluded that the anti-
Thy-1.2 serum was, in fact, absorbed by Thy-1.2-rich cells 
as determined by testing the antisera cytotoxicity a gainst 
BALB/ c thymocytes. Furthermore, cells frem any other 
tissue expressing the Thy-1. 2 antigen would also be ex-
pected to have the capacity t o absorb the activity of the 
antiserum. 
Survey of the Capacity of Bone !'larrows from 
Mice of Genetically Different Donors to Absorb 
the Activity of Anti-Thy-1. 2 Serum 
In preliminary attempts to verify the inability 
of BALB/c bone marrow cells to absorb anti-Thy-1 . 2 
serum diluted 1:40 it was discovered that bone marrow 
from these donors displayed very high capacity for re-
moving the activity . It was there f ore decided that 
the validity of the assay technique would have to be 
proven before proceeding with the next step of the ex-
periment . As a result , bone marrow cells from AKR/J 
mice were tested for their ability to absorb the anti-
Thy-1.2 sera ; AKR/J mice express the alternate allelic 
form of the antigen, Thy-1.1, instead of the Thy-1.2 
antigen. Therefore the AKR/J bone marrow would be the 
proper negative control for absorption ability. 
Since the BALB/c marrow showed the surprisingly 
high ability to absorb the antiserum, it was postulated 
that bone marrows from other Thy-1.2+ mouse strains 
mi~~t also be able to exhibit similar abilities. In 
order to determine the existence of a variation in 
Thy-1. 2 antigen expression by bone marrow cell popula-
tions, bone marrows from BALB/c, C57BL/6, and C3H mice 
were tested in addition to the AK R/J marrow. Graded 
numbers of bone marrow cells suspended in 0 . 10 ml RPMI 
from each mouse strain were incubated with 0 .10 ml of 
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anti-Thy-1.2 serum diluted 1 :10 or 1 :20 in RP~lI . Follow-
ing the incubation step, cell free supernatants were 
collected and tested for residual cy totoxicity a gainst 
BALB/c thymocytes; the results of the assay were ex-
pressed as /6 absorption of ant i - Thy-1. 2 activity . 
The results of the absorption of t he 1: ?0 dilution 
of antiserum (Table I) indicate that the AK R/J marrow, 
as expected, was unable t o a bsorb Signi f icantly the anti-
serum; the C3H c ells '.~ere also unable to remove the ac-
tivit~ I n contrast, the C57BL marrow showed indications 
of being able to remove the activity , and the BALB/c 
marrow a gain s howed marked absorption ability. 
Table II pre,'ents the results of the absor ption 
of the 1:10 dilution of antiserum with a panel of cells 
identical to those reported in Table I . In this experi-
ment the marrows from AKR/J, C3H, and C57BL were all 
unable to remove the activity ; however, the BALB/c 
marrow continued to absorb the activity with cell con-
centrations of 5 x 106/0.1 ml and above . 
TABLE I 
ABSORPTION OF ANTI- 9 SERU~l DILUTED 1 :20 BY BONE 
!'JARROW CELLS F RO!'] NICE OF DIFFERENT INBRED STPAINS 
Number of cells % absorption of activity 
used to absorb incubation \~i th marro>1 from 
the antiserum 
BALB/c C57BL C3H AK R/J 
o ( m oil) 0 0 0 0 
104 0 1 . 3 0 0 . 7 
105 4 . 3 3 . 7 0 4 . 5 
106 23 . 2 2 .4 1 . 3 0 
2 x 106 36 . 6 26 . 9 9 . 4 7 . 8 
5 x 106 24 . 6 8 . 6 6 . 7 3 . 2 
107 40 . 7 17 . 1 NT " NT" 
* Not tested 
TABLE II 
ABSORPTION OF ANTI- 9 SLRUfoi DILUTED 1 :10 BY BONE 
MARHOVI CELLS 1" ROl'! NICE OF DIFFERENT INBRED STHAINS 
Number of cells % absorption of a c tivity upon 
used to absorb incubation wi"Ch marrOl'/ from 
the antiserum 
BALB/c C57BL C3H AKR/J 
o e RPlU ) 0 0 0 0 
104 1 . 1 0 0 0 
105 0 0 0 0 
106 7 . 5 0 0 0 
2 x 106 1 . 1 0 0 0 
5 x '106 35 . 5 8 . 8 0 0 
10 7 100 . 0 NT ' NT ' 
, Not tested 
As a result of the survey just described, it was 
determined that the procedures used in the initial ab-
sorption studies were valid and merely reflected a 
relatively l arge amount of Thy-1.2 antigen expression 
in the BALB/c bone marrow cells . In view of the fact 
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that the 1:20 dilution of antiserum was heavily absorbed 
by BALB/c marrows, it was concluded that the 1:10 dilu-
tion would have to be used in t he subsequent experiments 
designed to determine whether or not bone marrow could 
be induced to express Thy-1. 2 antigen by the various 
treatments. Furthermore, the results of the absorption 
experiments also indicated that 2 x 106 BALB/c marrow 
cells/.1 ml would be the highest concentration of 
cells which could safely be used in the induction ex-
periments without resulting in absorption caused by 
the natural expression of the antigen by the untrea ted 
marrow cel l s. 
Ability of BALB/c Bone ~larrow Cells to 
Absorb Anti -Thy-1.2 Serum after 
Incubation with Isologous Anti-
C5?B L Immune Sera 
In order to dete rmine if BALB/c bone marrow cells 
could be induced to absorb anti-Thy-1. 2 serum (i .e., 
induced to express more Thy-1.2 antigen than controls), 
BALB/c anti-C57BL immune sera (described previously) 
were incubated with the BALB/c marrow cells, the latter 
of which were subsequently assayed for their ability to 
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absorb an t i-Phy-1.2 serum. Aliquots of 4 x ~06 bone 
marr ow cells suspended in 0 . 20 ml of RPMI were incubated 
with equal volumes of the expe rimental sera collected on 
day s 0 , 4 , 8 , 12 , and 16 . Following this preliminary 
incubation (i .e., the treatment stage), the cells were 
centrifuged and resuspended in 0 . 20 ml of anti- Thy-1. 2 
serum d i l uted 1:10 . After incubation with the antiserum, 
the suspensions were centrifuged and the supernatants 
were diluted in l{P~lI and tested for re sidual cytotoxic 
activity against BALB/c thymocytes. 
The results of the experiments pre sented in Ta ble 
III reveal two important points . Firstly , due to the 
high titer of antiserum used in the absorption steps, 
the cytotoxic ity assay was found to be insensitive when 
performed with the 1:10 , 1: 20 , 1:40 , and 1: 80 dilutions 
of antiserum. Secondly, the bone marrow cell s which 
were incubated with immune sera collected on day 4 and 
day 8 displayed a marked abili ty to absorb anti- Thy-1. 2 
serum compa red to cells incubated with normal (day 0) 
serum (Figure 4). Although cells incubated with immune 
s era collected on days 12 and 16 exhibited less absorp-
tive ability than those of days 4 and 8 , those c e lls 
were more capable of absorbing the activity than the 
cells incubated with control serum. 
Ability of BALB/c Bone Marrow Cells to 
Absorb Anti-Thy-1.2 Serum After 
I ncubation with ISOlogous Immune 
Sera and with LPS 
In a companion effort to the precedi ng experiment, 
TABLE III 
COMPARISON OF CYTOTOXIC INDICES OF ANTI-THY-1.2 
SERUM ABSORBED AGAINST CELLS INCUBATED 
WITH EXPERIMENTAL SERA ONLY 
Dilution of BALB/c Marrow Cells 
absoI"bed Treated with Serum Collected 
anti- Thy-1.2 Day Day Day Da y Day 
serum tested 0 4 8 12 16 
1 :1 0 . 85 . 91 . 86 . 94 . 86 
1: 20 . 85 .92 . 90 . 88 . 83 
1: 40 . 82 . 84 . 84 . 81 . 81 
1 : 80 . 83 . 80 . 70 . 48 . 74 
1 :1 60 . 74 . 24 .46 .49 . 26 
1:320 . 38 . 05 . 05 . 19 . 35 
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RPM I 
Sham 
. 95 
. 89 
. 89 
. 84 
. 65 
. 59 
NOTE: 'I'he anti- Thy-1. 2 serum diluted 1 :10 was a bsorbed 
aGainst the treated bone marrO~1 cells; the 
"dilutions " re fe rred to in this table we re 
made after t he absorption stage of t he experiment . 
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Figure 4 . Cytotoxi~ I ndex vs . serum dilution (anti-Thy-1 . 2 serum absorbed a gainst bone marrow 
cells previously incubated with day 0 , day 
4 , and day 8 immune sera) . 
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BALB/c marrow cells which were first treated with anti-
C57BL immune serum were subsequently incubated with LPS. 
Since LPS has been shown to influence Thy-1.2 antigen 
expression in mouse bone marrow cells(28), it was pos-
tulated that incubation of the immune serum treated cells 
might effect an even higher level of antigen expression 
which would be revealed by increased anti-Thy-1.2 serum 
abso~ption capacity. 
For the purpose of testing this idea it was de-
cided that the experimental conditions preceding; the 
incubation of the marrow cells with the LPS should be 
exactly the same as the conditions in the experiment 
which tested the inductive effects of the immune sera 
(above). Twin BALB/c cell dilutions were prepared before 
either of the experiments wa s begun; and a single 
series of anti-Thy-1. 2 s e rum dilutions was u t il ized 
as the source of antiserum in both experiment s. Thus 
the experiments were run in tandem until the point at 
which the cells had completed the incubation with the 
anti C57B L immune sera. At that point one group of 
cells was used to absorb the anti-Thy-1.2 serum and 
the remaining group was incubated with 0.20 ml of LPS 
at a concentration of 5 ~g/0 . 1 mi . 
Subsequent testing of the absorptive capacity 
of the second group of cells revealed that those cells 
had essentially no ability to absorb anti-Thy-1.2 
serum (Table IV). The only exception to the prece 
ing statement was noted in the cells incubated with 
TABLE IV 
COMPARISON OF CYTOTOXIC INDICES OF ANTI-THY-1.2 
SERUM ABSORBED AGAINST CELLS INCUBATED 
,11TH EXPERIMENTAL SERA AND LPS 
Dilution of BALB/c Marrow Cells 
absorbed Treated with Serum Collected 
anti-Thy-1.2 Day Day Day Day Day 
serum tested 0 4 8 12 16 
1 :1 0 . 91 . 92 . 82 . 83 . 86 
1 :20 . 88 . 86 . 81 . 81 . 84 
1 :40 
.73 . 78 .79 . 70 . 73 
1 : 80 . 71 .67 . 71 . 54 . 65 
1:160 
. 57 . 45 .l;8 . 47 . 46 
1: 320 .iT5 . 08 . 50 . 53 . 28 
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RPM I 
Sham 
. 86 
. 91 
.82 
. 76 
.42 
. 32 
NOTE : The anti- Thy- 1.2 serum dilut ed 1:10 was absorbed 
against the treated bone marrow cel l s ; the 
"dilutions" referred to in t his table were 
made after the absorption sta~e of the experiment . 
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day 4 immune serum and LPS ; in this group of cells there 
was an increased a bsorptive capacity as revealed hy the 
results of the cytotoxicity assay of the 1 : 320 dilution 
of antiserum . 
From the results obtained in this experiment, 
it was concluded that either LPS caused the cells which 
had previously been induced to express the Thy-1 . 2 anti-
gen to differentiate further to a stage in which they 
no longer expressed the antigen, or possibly the LPS 
effected antigenic modulation or in some other way 
caused the cells to mask the antigen . 
DISCUSSION 
Although the bone marrow of the adult rodent has 
been identified as a s ource of pre thym ic stem cells 
(24, 26), there have been conflicting reports concerning 
the presence of detectable T l ymphocyte s in that tissue . 
Bone marrow T cells have been variously described as 
being nor. ex~stent ( 27) , impossible or difficult to find 
(25), present in low proportion, and present in different 
amounts,depending on the genetic background of the mouse 
strain tested (1 3) . The situation has been further com-
plicated by the fact that certain funct ions and proper-
ties which are generally attri buted to T cells are 
present i n the bone marrow in the absence of de t ectable 
T cells or out of proportion to the number of detectable 
T cells there (28). Additionally , research efforts 
directed to\·/ard uncloaking the true identity of the 
normal bone marrow constituents have t ypically assayed 
either the func tional maturity of the cells or the 
surface anti gen maturity of the cells, but not both 
simul taneously . 'J'hu.s it has been difficult to correlate 
data for the purpose of defining T cell maturity . 
The results in this paper strongly support pre-
vious ~/ork which suggested that genetic variation exists 
in mouse bone marrow cells regarding the capacity of cells 
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from different donor strains to abs orb anti~hy-1. 2 
serum (13, 25) . This absorptive capaci ty has been 
interpreted as an indicator of the presence or absence 
of the Thy- 1 . 2 antigen in tissues (11, 20) . Narrow 
from C57BL mice has been reported to express a high 
degree of absorptive ability as compared to BALB/c 
marrow \'lhich has been characterized as being essen-
tially void of detectable T cells (27) . In contrast t o 
those reported data, BALB/c marrow in the experiment 
described herein consistently exhibited a high capacity 
for a bsorption of the anti Thy- 1 . 2 serum, while C57BL 
marrO~lS were prac tic ally unable to remove any of the 
antiserum's activity . 
The negative results obtained ~li th the AK R/ J 
marro\. are consistent \'Ti th previous reports (1 6 , 20) 
and reaffirm the absence of the ThY- 1 . 2 ant i gen in the 
tissues of mice from Thy- 1 . 1 + donors . C3H marrow cells, 
although Thy-1. 2+, were unab le to remo ve antiserum 
activity any more t han t he AKil/J marrow cells tested . 
However , normal C3H bone ma r r ows have been demonstrated 
t o possess some of the i'unct ional capabili t ies \.hich 
are hallmar ks of the T cells (10) . This situation is 
apparently an example of t he phenomenon mentioned a bove, 
to \'Ii t, functional capacity and surface antigen expres-
sion evidently are not mutually dependent occurences . 
An intensive probe into the correlation between surf'ace 
antigen expression and functional capacity in bone 
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marrow cells regarding helper , suppres s or , and effector 
functions I~ou ld be a I.elcome addition to existing 
literature . 
The observation in this work t hat BALB/c marrow 
cells incubated with the serum collected f rom antigen-
challenged (spleen- allografted ) hos ts exhibited an en-
hanced capacity for absorbing anti- Thy- 1 . 2 serum has not 
been previ ously reported . The i mplications of these 
results , I.hen correlated t o the existing body of know-
ledge dealing I.i th T- cell produc tion , open the door to 
a new line of research poss i bilities . 
If it can be assumed that the increased antiserum 
absorption by the bone marrow cells I-las due t o the 
increased expression of t he Thy- 1 . 2 surfac e antigen on 
T c ells , then it would be logical to i nterpret these 
data as offering testimony to the ex istence of a facto r 
in the immune serum which is capa ole of ef fectin g T- c ell 
differentia tion . Furt hermore, i f i t I-Ie re demonstrated 
that , as a result of the action of t his factor, t he 
bone marrow cells had an increased T- cell f unctional 
capacity then it would not e diff icult to postulate 
a model describing a physiolo -ical regulatory mechanism 
-,'/hich I.ould be ac tive in the immune response . 
I t seems unlikely that the presence of Thy- 1.2 
surface antigens on bone marrow cells would not b~ an 
indication of f unctiona l potential . Hecent work has 
demonstrated a gain and a gain that bone marrow cells 
can be s t imulated t o express the Thy-1 antigen as well 
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as t o increase functi onal capacity by a variety of 
a gen ts whic h include thymic fac t or (2, 21, 22) , 
concavalin A, phytohemagglutinin, lipopolysaccharide 
(28), and corticosteroids (29), to mention only a f ew. 
It is generall y accepted that these a gents act to stim-
ulate the cell' s adeny l cyc lase sys t em by an unexplained 
mechani sm (30) . From the above studies, it seems clear 
that t here are T- cell precursors in the murine bone 
marrows; it is not clear, however , whether or not 
t her e are mature T cells in bone marrovl , whether or 
not the presence of s uch mature T ce l ls in t he bone 
marrow is variable between mouse s t rains , or whe ther 
the presence of t he mature T cel l s i n the bone ~arrow 
is the result of in situ produc t ion or a r ef lect ion of 
transient circulatory T cells . These r esults do seem 
to r efute previous reports ( 28) t hat t he presenc e of 
T c ells in the bone marrO\~ is merely due to the s equest-
e ring of c ircu l ating T c ells by t he bone marrow . 
An interesting observat i on of the present work 
was that BALB/ c bone ma r row cells , when incubated with 
bacterial lipopolysaccharide aft e r prior treatmen t 
with the i mmune serum, lost the previously demonstrated 
ability to absorb anti-Thy-1. 2 serum. Possibl y , the 
LPS induces the furthe r differentiat ion of the previously 
Thy-1.2+ cells to a stage of development in whic h 
the ThY-1. 2 antigen is no longer expressed or expressed 
in a much reduced proportion . Evidence supporting 
such an i nterpretation has been previously established 
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( 28) by data II/hich suggest that LPS induces T-lympho-
blast f ormation and that these cell types are generally 
Thy-1. 2-. 
Many fragmented theories exist regarding the 
sequence of events in T-axis cell maturation (10, 17, 
19 , 26 , 31, 32) . Accordin g to one ( 32), the immature 
(immunoincompetent) thymus cells expresses a high 
amount of TI,y-1 antigen on its surface (in addition to 
other antigens) ; and, as the cell ma tures t o an 
immunocompetent cell, it ceases to express a large 
portion of the Thy-1 antigen . By t his theory , t he pre-
thymic cell (in the bone marroll/) I-lOuld al ready be com-
mitted t o T-cell program activity as a result of some 
unknown f actor influencing the differentiation of the 
uncommitted stem cell to enter into t he pre- T- cell line . 
With the above information in mind , the results 
of t !1e present research could be explained as f ol lows : 
The substance released i nto the s erum of t he graf t -
rejecting mice could f unction as a feedback signa l to 
t he bone marrow . I n the bone marrow , th e released 
(circulating ) f actor could stimulate the diff erentiation 
of th e pr e t hymic cell (comm i tted to T- cell program) 
into the i mmature (immunoincompetent) T cell which , 
as I'/e have previously stated, expresses a greater amount 
of the Thy-1 antigen on its surface (upon absorbing 
anti-Thy-1.2 serum a gainst such a cell population , one 
would naturally expect that the resulting anti- Thy-1.2 
serum ~/ould have a reduced titer of anti-thymocyte 
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activity). If LPS acts at the level of the immature 
(immunoincompetent) T cells t o stimulat e further 
deve lopment of the cells to the mature (immunoincompetent) 
state (case #1), or even if the sti mul us were applied at 
the level of the prethymic stem cell level (committed 
to T-cell program) in the bone marrow ( case #2 ) , the 
resul t of such a treatment could possibly be a reducti on 
of the amount of Thy- 1 surfac e antigen previously ind:lced 
in the cell by treatment with i mmune serum . This could 
be due to a reduction in the amount of detectable Thy- 1 
antigen caused by the direc t maturation of the bone 
marrow prethymic stem cells t o mature T ce l ls (101" 
Thy-1, i mmunocompetent) . In case #1, the existing 
i mmature (high Thy- 1 , i mmun oincompetent ) cells could 
logically also be stimulated to maturity bj" the LPS . 
It is i mportant t o bear in mind that the data 
presented in this work are by no means conclusive . 
Howeve r , in consideration of this and othe r vlor}:s , it 
seems l ogical that the regulation of bone ~arrow T 
cell diff erentiation can be under the contr ol of factors 
that are released into the circulation of an animal 
conf ronted ~Ii th an ant i e;enic chal lenge ; s uc h a situa tion 
would provide a signal bac k to the bone marrow t o 
i nduce precursors t o diff erentiate into "Ihatever subset 
of T cells were in the host ' s response to the c halle nge . 
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APPENDIX 
Abbreviations Used in this Work 
C. l . 
GIBCO 
LPS 
PBS 
RPNI 
RPI~I-FC S 
e 
Thy-1. 
Theta 
Cytotoxic Index 
Grand Island Biological Company , Grand 
Island , New York . 
Bacto Lipopolysacchande Iv ., E. coli 0111 : B4, 
Difco Laboratories, Detroit, MIch1gan . 
Dul becco ' s phosphate buffered saline, pH 7. 3 • 
Tissue culture medium ; RPMI 1640 with 
gl utamine ; penicillin 100 units/ml and 
str eptomycin 100 ug/ml added . 
RPNI prepared as above with Fetal Calf 
Serum added as 10% of the total volume . 
these are the var ious s ymbols used to describe 
a s ingle cell surf ace ant i gen associated 
with the Cell Nediated Immune system. 
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